Harrow Health Q1 2024 Adj EPS $(0.28) Misses $(0.20) Estimate, Sales $34.600M Miss $37.268M Estimate
Harrow Health Q1 2024 Adj EPS $(0.28) Misses $(0.20) Estimate, Sales $34.600M Miss $37.268M Estimate
Harrow Health 2024 年第一季度经调整后每股收益 (0.28) 未达到预期 (0.20) 美元，销售额为 3,460 万美元，低于预期 3,7268 万美元
Harrow Health (NASDAQ:HROW) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.20) by 40 percent. The company reported quarterly sales of $34.600 million which missed the analyst consensus estimate of $37.268 million by 7.16 percent. This is a 32.55 percent increase over sales of $26.103 million the same period last year.
哈罗健康（纳斯达克股票代码：HROW）公布的季度亏损为每股0.28美元，比分析师普遍预期的0.20美元（0.20美元）低40％。该公司公布的季度销售额为3,46亿美元，比分析师普遍预期的3726.8万美元低7.16％。这比去年同期的2610.3万美元的销售额增长了32.55％。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。